Federal Register / Vol. 61, No. 115 / Thursday, June 13, 1996 / Notices 30089

Dated: March 25, 1996.

Michael H. Trujillo,

Assistant Surgeon General, Director.

[FR Doc. 96–14952 Filed 6–12–96; 8:45 am]

BILLING CODE 4160–16–M

National Institutes of Health

Proposed Collection; Comment

Request; Agricultural Health Study—A

Prospective Cohort Study of Cancer

and Other Diseases Among Men and

Women in Agriculture

SUMMARY: In compliance with the

requirement of Section 3506(c)(2)(A) of

the Paperwork Reduction Act of 1995,

for opportunity for public comment on

proposed data collection projects, the

National Cancer Institute (NCI), the

National Institutes of Health (NIH) will

publish periodic summaries of proposed

projects to be submitted to the office of

Management and Budget (OMB) for

review and approval.

PROPOSED COLLECTION: Title:

Agricultural Health Study—A

Prospective Cohort Study of Cancer and

Other Diseases Among Men and Women

in Agriculture. Type of Information

Collection Request: Revision (0925–

0406, expiration 8/31/96). Need and Use

of Information Collection: The

Agricultural Health Study is in its third

year of data collection on a prospective

cohort of 75,000 farmers, their spouses,

and commercial applicators of

pesticides from Iowa and North

Carolina. Baseline questionnaires have

been completed by these applicators

and by spouses of the farmer

applicators.

These questionnaires collected

information about demographics,

occupational history, medical history

and family medical history. Frequency

of Response: Single time reporting.

Affected Public: Individuals or

households, Farms. Type of

Respondents: Private pesticide

applicators and their spouses. The

annual reporting burden is as follows:

Estimated Number of Respondents:

13,590; Estimated Number of Responses

per Respondent: 1.0; Average Burden

Hours Per Response: .6143; and,

Estimated Total Annual Burden Hours

Requested: 8,348. The annualized cost

to respondents is estimated at: $83,480.

There are no Capital Costs to report.

There are no Operating or Maintenance

Costs to report.

REQUEST FOR COMMENTS: Written

comments and/or suggestions from the

public and affected agencies are invited

on one or more of the following points:

(1) Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

function of the agency, including

whether the information will have

practical utility; (2) Evaluate the

accuracy of the agency’s estimate of the

burden of the proposed collection of

information, including the validity of

the methodology and assumptions used;

(3) Enhance the quality, utility, and

clarity of the information to be

collected; and (4) Minimize the burden

of the collection of information on those

who are to respond, including the use

of appropriate automated, electronic,

mechanical, or other technological

collection techniques or other forms of

information technology.

FOR FURTHER INFORMATION: To request

more information on the proposed

project or to obtain a copy of the data

collection plans and instruments,

contact Michael C.R. Alavanja, Dr. P.H.,

Epidemiology and Biostatistics Program,

Division of Cancer Etiology, National

Cancer Institute, EPN 430, 6130

Executive Boulevard, Rockville, MD

20852, or call (310) 496–9093, or E-mail

your request, including your address to:

alavanjamepndce.nci.nih.gov.

COMMENTS DUE DATE: Comments

regarding this information collection are

best assured of having their full effect if

received by no later than August 12,

1996.

Dated: May 31, 1996.

Philip D. Amoruso,

NCI Executive Director.

[FR Doc. 96–15057 Filed 6–12–96; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meeting:

Name of SEP: Sickle Cell Disease Therapy.

Date: June 20–21, 1996.

Time: 7:30 p.m.

Place: Holiday Inn, Chevy Chase, 5522

Wisconsin Avenue, Chevy Chase, Maryland

20815.

Contact Person: Ivan Baines, Ph.D., Two

Rockledge Center, Room 7184, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0277.

Purpose/Agenda: To review and evaluate

grant applications.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less

than fifteen days prior to the meeting

due to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: June 10, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–15056 Filed 6–12–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Environmental

Health Sciences; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting:

Name of Committee: Environmental Health

Sciences Review Committee.

Date: July 29–30, 1996.

Time: 8:30 a.m. to Adjournment.

Place: National Institute of Environmental

Health Sciences, Building 101, Conference

Rooms A and B, South Campus, Research

Triangle Park, North Carolina.

Contact Person: Dr. Ethel Jackson,

Scientific Review Administrator, P.O. Box

12233, Research Triangle Park, NC 27709,

(919) 541–7826.

Purpose: To review and evaluate grant

applications.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.113, Biological Response to

Environmental Health Hazards; 93.114,

Applied Toxicological Research and Testing;

93.115, Biometry and Estimation; 93.894,

Research and Manpower Development,

National Institutes of Health)

Dated: June 10, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–15053 Filed 6–12–96; 8:45 am]

BILLING CODE 4140–01–M